Literature DB >> 10094557

Detection of protein truncating mutations in exons 1-14 of the APC gene using an in vivo fusion protein assay. Mutations in brief no. 214. Online.

C Andreutti-Zaugg1, A Couturier, P Chappuis, P Hutter.   

Abstract

About 80% of the mutations identified to date in the Adenomatous Polyposis Coli (APC) gene have been found in the 5' half of the coding sequence, the vast majority of which (>95%) are nonsense or frameshift mutations that result in the loss of the carboxyl terminus of APC protein. Using a stop codon assay in yeast recently developed by others (Ishioka et al., 1997), we have screened the 5' half of the APC gene for mutations in 7 unrelated families affected with Familial Adenomatous Polyposis. The assay relies on the expression of a yeast reporter gene fused in frame to one of 3 contiguous segments of the APC open reading frame. Here we report on the detection by this assay of 5 germline mutations, 4 of which lie upstream of exon 15, where lesions appear to be sometimes difficult to detect by standard methods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094557     DOI: 10.1002/(SICI)1098-1004(1999)13:2<170::AID-HUMU12>3.0.CO;2-7

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  2 in total

1.  APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations.

Authors:  Per Arne Andresen; Ketil Heimdal; Kristin Aaberg; Katrine Eklo; Kristin Eklo; Sarah Ariansen; Alexandra Silye; Olav Fausa; Lars Aabakken; Stefan Aretz; Tor J Eide; Tobias Gedde-Dahl
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-15       Impact factor: 4.553

2.  Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.

Authors:  A Rohlin; Y Engwall; K Fritzell; K Göransson; A Bergsten; Z Einbeigi; M Nilbert; P Karlsson; J Björk; M Nordling
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.